Live tape
Top 8, mentions 7d11,746TSLA2,433 mentions▲ +0.06SPCX1,949 mentions▲ +0.08GOOGL1,621 mentions▲ +0.04CRWV1,450 mentions▲ +0.03NVDA1,239 mentions▲ +0.07QQQ1,202 mentions▲ +0.05NBIS947 mentions▲ +0.06META905 mentions▲ +0.05

Equity · Healthcare

ASTH

NASDAQ

Astrana Health (ASTH)

$36.93 −0.19% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 19, 2026
Price · Chart
63 sessions
$42.5 $32.5 22 Jul 19 Oct

The line runs $42 on 22 July through $36.93 on 19 October, on a scale from $32.5 to $42.5. Days the market did not trade hold the previous close, flat.

Market cap $2.1B
P/E (TTM) 45.0
52-week range $18.14 – $49.81
Avg volume 16.3K

as of Oct 19, 2026

Astrana Health (ASTH) insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 10 Oct 2026

In the 90 days to 21 Oct 2026, no Astrana Health insider bought or sold shares on the open market; all 11 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Open-market buys 0
Open-market sells 0
Non-trade filings 11

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
10 Oct 2026 Vong John SVP - Accounting (PAO) Tax withheld 556 $21K
06 Oct 2026 Sim Brandon CEO and President Tax withheld 9,889 $366K
06 Oct 2026 Lam Thomas S. Director Tax withheld 2,624 $97K
02 Oct 2026 Basho Chandan COO and CFO Tax withheld 2,092 $75K
15 Sep 2026 Vong John SVP - Accounting (PAO) Tax withheld 96 $4K
05 Sep 2026 Sim Brandon CEO and President Tax withheld 7,163 $276K
05 Sep 2026 Basho Chandan COO and CFO Tax withheld 1,790 $69K
31 Aug 2026 Kitayama Mitchell W Director Other 8,500 $315K
14 Aug 2026 Schmidt David Director Option exercise 20,000 $100K
14 Aug 2026 Schmidt David Director Other 20,000 $772K
07 Aug 2026 Sobotka Glenn Other 11,793

Astrana Health (ASTH) reported financials

SEC EDGAR XBRL SEC EDGAR

Astrana Health reported revenue of $3.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $22.5M.

Figure Reported Period
Revenue $3.2B 31 Dec 2025 fiscal year
Net income $22.5M 31 Dec 2025 fiscal year
Diluted EPS $0.46 31 Dec 2025 fiscal year
Total assets $2.3B 30 Jun 2026 at period end
Total equity $830.2M 30 Jun 2026 at period end

Astrana Health (ASTH) earnings

SEC EDGAR

Astrana Health last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.40; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.40 —
31 Mar 2026 Q1 2025 $0.29 —
31 Dec 2025 FY 2025 $0.46 —
30 Sep 2025 Q3 2025 $0.01 —
30 Jun 2025 Q2 2025 $0.19 —
31 Mar 2025 Q1 2025 $0.14 —
31 Dec 2024 FY 2024 $0.90 —
30 Sep 2024 Q3 2024 $0.33 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Astrana Health (ASTH) institutional holders (13F)

SEC Form 13F SEC EDGAR

5 of the 45 institutional funds we track reported a Astrana Health position for the quarter ended 30 Jun 2026 — a combined $15.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +1,122.1% shares 190,503 $8.8M
Renaissance Technologies Trimmed −28.6% shares 74,646 $3.5M
Citadel Advisors Held (±25%) +0.2% shares 25,069 $1.2M
Man Group Trimmed −87.8% shares 18,639 $865K
AQR Capital Management Trimmed −48.7% shares 17,628 $818K

Astrana Health (ASTH) fails-to-deliver

SEC CNS data SEC

On 29 Sep 2026, 2,319 shares of Astrana Health failed to deliver (about $81K).

Settlement date Shares failed Notional % of shares out
29 Sep 2026 2,319 $81K 0.004%
16 Sep 2026 30,861 $1.2M 0.055%
08 Sep 2026 755 $29K 0.001%

Congressional trades in Astrana Health (ASTH)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Astrana Health is a sale by Judy Chu (house, CA), dated 19 Aug 2025.

Date Member Type Amount
19 Aug 2025 filed 30 Aug 2025 Judy Chu house · Democrat–CA Sale $100K–$250K

Astrana Health (ASTH): frequently asked questions

From live data

Have Astrana Health insiders bought or sold shares recently?

In the 90 days to 21 Oct 2026, no Astrana Health insider bought or sold shares on the open market; all 11 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

How many institutions hold Astrana Health?

5 of the 45 institutional funds we track reported a Astrana Health position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Astrana Health had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Astrana Health is dated 29 Sep 2026, when 2,319 shares failed to deliver.

When did Astrana Health last report earnings?

Astrana Health last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.40; no next date is announced in SEC filings yet.

What exchange is Astrana Health listed on?

Astrana Health trades on NASDAQ under the ticker ASTH.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings